glp-1 modere GLP Weight Loss Medications GLP-1 Medications for Weight Loss:

It is contraindicated in patients with a personal or family history of medullary thyroid cancers (MTC) or patients with multiple endocrine neoplasia syndrome type 2 (MEN2).[30] FUTURE INDICATIONS AND TRIALS Oral semaglutide has been explored with higher doses of 25 and 50 mg in ongoing PIONEER plus trials.[39] Another trial under the name PIONEER TEEN is ongoing to see the efficacy and safety of semaglutide in children and teenagers with age 10 years to 17 years.[40] PIONEER REAL is a global prospective, non-interventional single-arm real-world study with oral semaglutide.[41] EVOKE and EVOKE plus are ongoing trials to see the effect of oral semaglutide in Alzheimers disease.[42] SOUL is an ongoing CV superiority trial with an objective to prove CV benefits with this molecule

The magnitude of weight loss achieved with Retatrutide translates to clinically meaningful outcomes

Phase 3 SURPASS trials began in 2019

"The brain determines how much fat or energy storage we should have, and we call that the defended fat mass set point," Jastreboff said

Ready for final dose increase to 12mg maintenance dose beginning week 13

Curr Diab Rep 22(3):117128